Please login to the form below

Not currently logged in
Email:
Password:

Peter Nightingale appointed as chair of new MHRA committee

Was formerly president of the Intensive Care Society

edit-MHRA-Peter-Nightingale-2Dr Peter Nightingale has been named as chairman of the MHRA's new Devices Expert Advisory Committee (DEAC).

The DEAC has been formed as a consequence on an independent review on MHRA access to clinical advice and engagement with the clinical community and will replace the Committee on the Safety of Devices.

Commenting on his appointment, Nightingale said: “I am delighted to be taking on this role. The new committee will play a vital role in providing expert advice for the MHRA on a huge range of medical issues and will help to ensure safe use and management of medical devices.”

Nightingale is a consultant in anaesthesia and intensive care medicine and was president of the Royal College of Anaesthetists until September 2012. He was also formerly president of the Intensive Care Society and vice chair of the Academy of Medical Royal Colleges.

John Wilkinson, MHRA Devices director, added: “I am delighted that Dr Nightingale has accepted this appointment at a time when the agency is busy implementing the recommendations of the review chaired by Professor Terence Stephenson into access to clinical advice.

“His expertise and experience will be invaluable in helping the agency as it responds to the demands of the future.”

2nd March 2015

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics